ArticleNature communications2026
Trimbody with rigid AI-designed scaffolds enables atomic-resolution cryo-EM structure determination of small proteins.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Cryo-electron microscopy (cryo-EM) single-particle analysis faces significant challenges in resolving the structures of small proteins due to low signal-to-noise ratios and insufficient structural features. Here, we present Trimbody, a simple yet robust method that leverages rigid AI-designed scaffolds to overcome these limitations. Trimbody comprises two components: a trimeric scaffold (H3-PrAC-5350A) and a reformatted nanobody fusion (Nb-TAIL). The de novo 3-helix bundle (H3) and TAIL domains, engineered via RFdiffusion and ProteinMPNN, stabilize the interactions between Nbs and the scaffold and enhance the overall rigidity of the system, thereby enabling high-resolution cryo-EM analysis. Using Trimbody, we resolve the atomic structures of four sub-50 kDa test proteins: human Gal10 (2.62 Å), Aequorea coerulescens GFP (2.29 Å), the IgV domain of human Nectin4 (2.43 Å), and membrane protein Escherichia coli LacY (2.50 Å), demonstrating the method's versatility. Trimbody's simplicity, cost-effectiveness, and compatibility with standard cryo-EM workflows position it as a universal tool for structural studies of small proteins, further advancing nanobody-based drug development and life science research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.